The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

IDE Group enters short-term loan agreement with MXC Capital

Wed, 08th Dec 2021 14:19

(Alliance News) - IDE Group Holdings PLC announced on Wednesday it had entered into a short-term loan agreement with private equity firm MXC Capital Ltd.

The Dorset-based IT service management company said the loan is for GBP1 million and carries an arrangement fee of 3.75%. The interest rate varies between 1.5% and 3%, with the rate being lower for quicker repayment. The loan will be unsecured and subordinated to the outstanding loan notes.

MXC had previously agreed to invest up to GBP9 million in IDE Group back in January 2019 by way of a subscription for secured loan notes. The notes had a term of six years, an annual coupon of 12%, and arrangement and exit fees of 2.5%.

MXC said it expects the new loan to be repaid by March 31. If the loan is not repaid by then, the terms will revert to the same terms as the outstanding loan notes announced in January 2019.

MXC is a related party of IDE as they are a substantial shareholder, holding a 43% stake, and because Ian Smith, chief executive of MXC is also the executive director of IDE.

Shares in IDE were up 2.0% at 1.30 pence each on Wednesday in London.

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
4 Nov 2022 20:38

TRADING UPDATES: SigmaRoc files patent; Griffin restarts operations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

26 Oct 2022 15:52

UK shareholder meetings calendar - next 7 days

30 Sep 2022 17:32

EARNINGS UPDATES: Harland & Wolff interim revenue climbs

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

29 Sep 2022 15:09

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

31 Aug 2022 21:41

TRADING UPDATES: ImmuPharma waits on FDA; IDE Group waits on audit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.